G3BP1 promotes human breast cancer cell proliferation through coordinating with GSK-3 beta and stabilizing beta-catenin

Ras-GTPase activating SH3 domain-binding protein 1 (G3BP1) is a multifunctional binding protein involved in the development of a variety of human cancers. However, the role of G3BP1 in breast cancer progression remains largely unknown. In this study, we report that G3BP1 is upregulated and correlated with poor prognosis in breast cancer. Overexpression of G3BP1 promotes breast cancer cell proliferation by stimulating beta-catenin signaling, which upregulates a number of proliferation-related genes. We further show that G3BP1 improves the stability of beta-catenin by inhibiting its ubiquitin-proteasome degradation rather than affecting the transcription of beta-catenin. Mechanistically, elevated G3BP1 interacts with and inactivates GSK-3 beta to suppress beta-catenin phosphorylation and degradation. Disturbing the G3BP1-GSK-3 beta interaction accelerates the degradation of beta-catenin, impairing the proliferative capacity of breast cancer cells. Our study demonstrates that the regulatory mechanism of the G3BP1/GSK-3 beta/beta-catenin axis may be a potential therapeutic target for breast cancer.